Frederick Stehman

  • 7321 Citations
  • 40 h-Index
1978 …2017

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Frederick Stehman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants

GYNECOLOGIC ONCOLOGY GROUP-INDIANA UNIVERSITY

Stehman, F. & Ehrlich, C. E.

National Institutes of Health

7/1/786/30/89

Project: Research project

  • Publications

    An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience

    Oliver, K. E., Brady, W. E., Birrer, M., Gershenson, D. M., Fleming, G., Copeland, L. J., Tewari, K., Argenta, P. A., Mannel, R. S., Secord, A. A., Stephan, J. M., Mutch, D. G., Stehman, F. B., Muggia, F. M., Rose, P. G., Armstrong, D. K., Bookman, M. A., Burger, R. A. & Farley, J. H., Nov 2017, In : Gynecologic oncology. 147, 2, p. 243-249 7 p.

    Research output: Contribution to journalArticle

  • 11 Scopus citations

    Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

    Tewari, K. S., Sill, M. W., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., Michael, H. E., DiSaia, P. J., Copeland, L. J., Creasman, W. T., Stehman, F. B., Brady, M. F., Burger, R. A., Thigpen, J. T., Birrer, M. J., Waggoner, S. E., Moore, D. H. & 3 others, Look, K. Y., Koh, W. J. & Monk, B. J., Oct 7 2017, In : The Lancet. 390, 10103, p. 1654-1663 10 p.

    Research output: Contribution to journalArticle

  • 89 Scopus citations

    Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study

    Rose, P. G., Java, J. J., Morgan, M. A., Alvarez-Secord, A., Kesterson, J. P., Stehman, F. B., Warshal, D. P., Creasman, W. T., Hanjani, P., Morris, R. T. & Copeland, L. J., Jan 1 2016, In : Gynecologic oncology. 143, 3, p. 511-515 5 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis

    Moore, K. N., Java, J. J., Slaughter, K. N., Rose, P. G., Lanciano, R., DiSilvestro, P. A., Thigpen, J. T., Lee, Y. C., Tewari, K. S., Chino, J., Seward, S. M., Miller, D. S., Salani, R., Moore, D. H. & Stehman, F. B., Nov 1 2016, In : Gynecologic oncology. 143, 2, p. 294-301 8 p.

    Research output: Contribution to journalArticle

  • 19 Scopus citations
  • 49 Scopus citations